Advances and Challenges in Prostate Cancer Diagnosis: A Comprehensive Review

Area of Science:

• Urology
• Oncology
• Radiology

Background:

• Prostate cancer is a leading cause of cancer mortality in men.
• Accurate diagnosis is crucial for effective treatment decisions.
• Multiparametric MRI (mpMRI) has improved prostate cancer detection and biopsy targeting.

Purpose of the Study:

• To provide a comprehensive overview of fusion biopsy in prostate cancer diagnostics.
• To highlight the evolving role and advancements in fusion biopsy techniques.
• To discuss clinical challenges and future directions in prostate cancer diagnosis.

Main Methods:

• Review of current clinical guidelines and emerging biopsy techniques.
• Integration of anatomical, epidemiological, technical, and clinical data.
• Exploration of mpMRI-TRUS fusion biopsy and penumbra-targeted sampling.

Main Results:

• mpMRI-TRUS fusion biopsy improves detection of clinically significant prostate cancer.
• Fusion biopsy reduces the overdiagnosis of low-risk prostate tumors.
• This technique enhances diagnostic accuracy and supports individualized patient care.

Conclusions:

• mpMRI-TRUS-guided fusion biopsy is a significant advancement in prostate cancer diagnostics.
• Fusion biopsy promotes precision oncology by minimizing overtreatment.
• Adoption of these innovations can improve patient outcomes and diagnostic accuracy.